MELODY TRANSCATHETER PULMONARY VALVE PB 10

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-01-22 for MELODY TRANSCATHETER PULMONARY VALVE PB 10 manufactured by Medtronic Heart Valves Division.

Event Text Entries

[176383762] Citation: georgiev s et al. A low residual pressure gradient yields excellent long-term outcome after percutaneous pulmonary valve implantation. Jacc: cardiovascular interventions. 2019; 12(16):1594-1603. Doi: 10. 1016/j. Jcin. 2019. 03. 037. Earliest date of publish used for event date. No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported. Without return of the product no definitive conclusion can be made regarding the clinical observations. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[176383763] Medtronic received information via literature regarding a prospective study into the long-term effectiveness of percutaneous pulmonary valve implants (ppvi). All data were collected from a single center between december 2006 and december 2017. The study population included 226 patients (unknown male/female distribution, median age 18 years, median weight 59kg), 220 of which were implanted with medtronic melody ppvis, 17 with medtronic contegra conduits, and 12 with medtronic hancock conduits (no serial numbers provided). Among all patients, 7 deaths occurred. Two of the deaths occurred from procedure-related complications, one from conduit rupture leading to severe bleeding and one from left coronary artery compression. One death occurred at 8 months post implant of the ppvi, likely due to a rhythm disturbance caused by low potassium levels. Four deaths occurred at 3 years to 7 years post implant of the ppvi for unknown reasons but possibly due to rhythm disturbances. No further details about the deaths were provided, and multiple manufacturer? S products were mentioned in the literature. Based on the available information medtronic product was not directly associated with the deaths. Among all medtronic melody patients, adverse events included: infective endocarditis, valve degeneration (stenosis), severe pulmonary regurgitation, elevated gradients. A total of 17 patients required intervention to replace the ppvi. Based on the available information medtronic product was directly associated with the adverse events. No additional adverse patient effects or product performance issues were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2025587-2020-00238
MDR Report Key9617826
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-01-22
Date of Report2020-01-22
Date of Event2019-06-12
Date Mfgr Received2020-01-09
Date Added to Maude2020-01-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactPAULA BIXBY
Manufacturer Street8200 CORAL SEA STREET NE
Manufacturer CityMOUNDS VIEW MN 55112
Manufacturer CountryUS
Manufacturer Postal55112
Manufacturer Phone7635055378
Manufacturer G1MEDTRONIC HEART VALVES DIVISION
Manufacturer Street1851 E DEERE AVE
Manufacturer CitySANTA ANA CA 92705
Manufacturer CountryUS
Manufacturer Postal Code92705
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMELODY TRANSCATHETER PULMONARY VALVE
Generic NamePULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Product CodeNPV
Date Received2020-01-22
Model NumberPB 10
Catalog NumberPB 10
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC HEART VALVES DIVISION
Manufacturer Address1851 E DEERE AVE SANTA ANA CA 92705 US 92705


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-01-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.